Showing results (331-340 of 3,787) with videos related to
Sort By:
Pageof 379
Oncoimmunology|February 10, 2012
PD-L1 co-stimulation, ligand-induced TCR down-modulation and anti-tumor immunotherapyKatarzyna Karwacz, Frederick Arce, Christopher Bricogne, et al.Oncoimmunology|October 24, 2014
Bone marrow-derived CD13+ cells sustain tumor progression: A potential non-malignant target for anticancer therapyEleonora Dondossola, Angelo Corti, Richard L Sidman, et al.Oncoimmunology|October 24, 2014
Trick and treat: Ambushing recurrent tumors before they get out of the doorNicolas Boisgerault, Richard G VileOncoimmunology|October 24, 2014
Of microspheres and microbes: A double-hit strategy for cancer immunotherapyBenjamin Brinkhoff, Thomas C WirthOncoimmunology|October 24, 2014
Adverse cardiac events to monoclonal antibodies used for cancer therapy: The risk of Kounis syndromeNicholas G Kounis, George D Soufras, Grigorios Tsigkas, et al.Oncoimmunology|November 19, 2013
Cell-in-cell: A virgin land of cell biologyYing Wang, Xiao-Ning WangOncoimmunology|November 19, 2013
Tumor-targeting vaccination instructs graft-vs.-tumor immune responsesTeresa Manzo, Rodrigo Hess Michelini, Tabea Sturmheit, et al.Oncoimmunology|November 19, 2013
Tumor-infiltrating follicular helper T cells: The new kids on the blockChunyan Gu-Trantien, Karen Willard-GalloOncoimmunology|November 19, 2013
Adoptive immunotherapy: New assay for the identification of T cells with optimal avidityBianca Weissbrich, Magdalena Nauerth, Dirk H BuschPageof 379